Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers C > Headlines for Calendar 2005 > News item |
FDA Calendar
Jan. 13, Gaithersburg, Md.
CIRCULATORY SYSTEM DEVICES PANEL OF THE MEDICAL DEVICES ADVISORY COMMITTEE (FDA)
Includes presentation on the FDA Critical Path Initiative and discussion on premarket approval application for a thoracic endoprosthesis for endovascular repair of the descending thoracic aorta
Jan. 13-14, Bethesda, Md.
JOINT MEETING OF THE NONPRESCRIPTION DRUGS ADVISORY COMMITTEE AND THE ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE (FDA)
Committees to consider the safety and efficacy of New Drug Application 21-213 for over-the-counter use of Merck & Co. Inc.'s Mevacor to help lower LDL cholesterol
Jan. 19-20, West Conshohocken, Pa.
CENTER FOR BUSINESS INTELLIGENCE CONFERENCE ON SCIENTIFIC STRATEGIES FOR INCREASING EFFICACY, SAFETY AND CONVENIENCE FOR THE NEXT GENERATION OF THERAPEUTICS
Focused on protein therapeutics on the market; includes presentation from Aegis Therapeutics on improvement of protein drugs and technology
Feb. 8-9, Houston
INDUSTRY EXCHANGE WORKSHOP ON FOOD AND DRUG ADMINISTRATION CLINICAL TRIAL REQUIREMENTS (FDA)
Workshop for clinical research community that targets sponsors, monitors, clinical investigators and institutional review boards
Feb. 27-28, Boston
2nd ANNUAL VIRAL HEPATITIS DRUG DISCOVERY & DEVELOPMENT SUMMIT
Focuses on research and technologies for hepatitis C and hepatitis B
April 26-30, Vienna, Austria
41st ANNUAL MEETING OF THE EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
Includes presentations on liver transplantation, cirrhosis, tumors and viral hepatitis
May 7-11, San Juan, Puerto Rico
19th INTERNATIONAL CONFERENCE ON ANTIVIRAL RESEARCH
Includes presentations on antiviral drug and antiviral chemotherapy research
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.